X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STRIDES SHASUN LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

STRIDES SHASUN LIMITED  (PLLB)


Here is the latest financial fact sheet of Strides Arcolab. For more details, see the Strides Arcolab quarterly results and Strides Arcolab share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
strides shasun ltd - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 1,148.3       No. of shares m 59.65
    Mkt Cap Rs m 68,496       % ch % 0.1
    Vol '000 281.5       % ch week % 0.4
    P/E X 17.8       % ch 1-mth % -1.8
    P/CF X 19.2       % ch 12-mth % 8.6
    EPS (TTM) Rs 64.5       52 week H/L Rs 1,259.0/918.0
(As on Mar 23, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-11
*
12
Dec-12
*
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs4551,2251,1381,1991,413 
Low Rs276372344384848 
Sales per share (Unadj.) Rs436.8163.6225.1200.6353.3 
Earnings per share (Unadj.) Rs38.5143.9296.6141.723.4 
Diluted earnings per shareRs37.6141.9296.2141.735.0 
Cash flow per share (Unadj.) Rs56.3149.2306.1152.541.0 
Dividends per share (Unadj.) Rs2.002.00505.00108.005.00 
Adj. dividends per shareRs1.961.97504.32107.957.49 
Dividend yield (eoy) %0.50.368.213.70.4 
Book value per share (Unadj.) Rs233.2344.6169.0192.0320.4 
Adj. book value per shareRs228.2339.7168.8191.9480.0 
Shares outstanding (eoy) m58.3858.8059.5759.6289.35 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x0.84.93.33.93.2 
Avg P/E ratio x9.55.52.55.648.3 
P/CF ratio (eoy) x6.55.42.45.227.6 
Price / Book Value ratio x1.62.34.44.13.5 
Dividend payout %5.21.4170.376.221.4 
Avg Mkt Cap Rs m21,33846,95844,13547,165100,988 
No. of employees `0003.02.71.52.04.7 
Total wages/salary Rs m3,0271,2031,5721,7214,988 
Avg. sales/employee Rs Th8,497.33,562.18,939.55,979.36,730.0 
Avg. wages/employee Rs Th1,008.8445.61,047.9860.31,063.6 
Avg. net profit/employee Rs Th748.03,134.211,778.34,225.0445.5 
  INCOME DATA
Net Sales Rs m25,5009,61813,40911,95931,564 
Other income Rs m3173426023861,212 
Total revenues Rs m25,8179,96014,01212,34432,776 
Gross profit Rs m4,9071,0062,2342,2895,213 
Depreciation Rs m1,0433095656401,573 
Interest Rs m1,9487951,0894741,803 
Profit before tax Rs m2,2322451,1831,5603,049 
Minority Interest Rs m-95-11-66127 
Prior Period Items Rs m0000-27 
Extraordinary Inc (Exp) Rs m4958,34019,7368,361-371 
Tax Rs m3871123,2451,476689 
Profit after tax Rs m2,2458,46217,6678,4502,089 
Gross profit margin %19.210.516.719.116.5 
Effective tax rate %17.345.5274.394.622.6 
Net profit margin %8.888.0131.870.76.6 
  BALANCE SHEET DATA
Current assets Rs m16,25314,10913,08614,29535,949 
Current liabilities Rs m27,91717,9737,07410,19919,402 
Net working cap to sales %-45.7-40.244.834.252.4 
Current ratio x0.60.81.81.41.9 
Inventory Days Days69168486371 
Debtors Days Days7718399119127 
Net fixed assets Rs m14,90115,6795,5067,35734,478 
Share capital Rs m584588596596894 
"Free" reserves Rs m11,56418,0394,5946,14022,601 
Net worth Rs m13,61420,26210,06811,44928,632 
Long term debt Rs m10,5437,3122,7552,67427,455 
Total assets Rs m53,64347,97520,99024,86176,591 
Interest coverage x2.11.32.14.32.7 
Debt to equity ratio x0.80.40.30.21.0 
Sales to assets ratio x0.50.20.60.50.4 
Return on assets %7.819.389.435.95.1 
Return on equity %16.541.8175.573.87.3 
Return on capital %19.034.0171.673.68.2 
Exports to sales %21.253.059.460.248.1 
Imports to sales %5.115.720.523.514.5 
Exports (fob) Rs m5,4055,0997,9597,20415,192 
Imports (cif) Rs m1,2901,5152,7522,8094,565 
Fx inflow Rs m6,3266,48222,79113,03116,612 
Fx outflow Rs m1,5141,8263,0883,1655,292 
Net fx Rs m4,8124,65619,7039,86511,320 
  CASH FLOW
From Operations Rs m 4,571 1,343 -2,717 834 717 
From Investments Rs m -6,565 8,065 40,771 519 -22,284 
From Financial Activity Rs m 894 -9,900 -33,185 -4,213 29,488 
Net Cashflow Rs m -1,100 -492 4,869 -2,860 8,073 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for strides shasun limited

 Share Holding
Indian Promoters : 27.7%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 37.8%
FIIs : 8.6%
ADR/GDR : 0.0%
Free float : 25.9%
Shareholders : 56,241
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
    E-MAIL: badree.komandur@stridesarco.com     WEB: www.stridesarco.com
    TELEPHONE: (080) 6784 0000     FAX: (080) 6784 0800
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 0.7

More pharmaceuticals Company Fact Sheets:   ALEMBIC LTDVENUS REMEDIESPIRAMAL ENTERPRISESASTRAZENECA PHARMAUNICHEM LAB


Today's Market

Sensex Closes Firm; NTPC Surges 2.3%(Closing)

Indian share markets continued to trade higher owing to firm global cues with energy stocks leading the gains, while financial stocks and auto stocks bounced back.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why You Should Try SCOREFASTTM Right Now(Daily Profit Hunter)

Mar 10, 2017

Asad Dossani discusses why SCOREFASTM will be a successful trading strategy

4 Things To Watch Out For After Modi's Landslide Win In UP Polls(Outside View)

Mar 15, 2017

PersonalFN explains why you need to wary while investing in equities despite Modi's UP win.

More

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - IPCA LABS COMPARISON

Compare Company With Charts

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS